Sestamibi Retention in a Breast Fibroadenoma in a Case of Hypercalcemia With Parathyroid Adenoma

Anaforoğlu I., Algun E., SAHIN R., OCAK I. H.

ENDOCRINOLOGIST, vol.20, no.1, pp.17-18, 2010 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 1
  • Publication Date: 2010
  • Doi Number: 10.1097/ten.0b013e3181cb480f
  • Journal Name: ENDOCRINOLOGIST
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.17-18
  • Recep Tayyip Erdoğan University Affiliated: Yes

Abstract

Primary hyperparathyroidism is the most common cause of hypercalcemia in nonhospitalized patients. Recently, technetium-99m sestamibi (methoxyisobutylisonitrile, Tc-99m MIBI) imaging has been established as the best method for detecting a parathyroid adenoma. However, sestamibi accumulates in a number of nonparathyroid tissues. We report a patient with suspected primary hyperparathyroidism, who underwent sestamibi parathyroid imaging. In addition to sestamibi retention in a parathyroid adenoma, retention was observed in a breast fibroadenoma, which mimicked an ectopic parathyroid adenoma.